13 results
8-K
EX-99.1
RNLX
Renalytix Plc
8 Apr 24
Regulation FD Disclosure
7:44am
”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), a specialty healthcare institutional investor focused on innovative medical technology
8-K
EX-99.1
RNLX
Renalytix Plc
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
growth in adoption. The social need could not be higher to establish the innovative preventative medicine strategies that KidneyIntelX technology
10-K
2023 FY
RNLX
Renalytix Plc
28 Sep 23
Annual report
6:18am
yield, ultimately increasing patient access to the benefits of innovative technology such as the FDA authorized KidneyIntelX.dkd.
Kidney disease … to support Medicare coverage on the national level for innovative diagnostic devices that service an urgent clinical need.
Build Substantial Repository
6-K
RNLX
Renalytix Plc
30 Nov 22
Current report (foreign)
7:31am
to occur. The social need could not be higher to establish innovative preventative medicine strategies such as KidneyIntelX at the front-end
6-K
EX-99.1
RNLX
Renalytix Plc
29 Nov 22
Current report (foreign)
7:01am
health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping
6-K
EX-99.1
44iglavpahtfa
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
6-K
EX-99.1
5wblt6krhpl2 e6dp
25 Oct 22
KidneyIntelX Medicare Update
10:30am
6-K
EX-99.1
t6au0v8k9kx vrlh
30 Nov 21
Renalytix plc Annual Report and Financial Statements FOR THE YEAR ENDED 30 JUNE 2021
4:15pm
6-K
EX-99.1
gf5s2x
21 Oct 21
Renalytix Reports Full Year Fiscal 2021 Results
6:09am
6-K
EX-99.1
vhl808 dkcig
2 Mar 21
RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021
6:10am
6-K
EX-99.1
zsbji5f
25 Nov 20
RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021
7:50am
20-F
ogp5d 9676
28 Oct 20
Annual report (foreign)
12:00am
- Prev
- 1
- Next